echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Research and development of a new generation of polypeptide antibiotics for super bacterial infection

    Research and development of a new generation of polypeptide antibiotics for super bacterial infection

    • Last Update: 2022-05-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    A collaborative team led by Professor Li Jian's laboratory at Monash University, Australia, recently published a paper online in the journal Nature Communications, reporting for the first time the development of a new generation of polypeptide antibiotic F365 (QPX9003)


    Since this century, bacterial resistance has become a huge threat to human health worldwide


    Polymyxins, first discovered in the 1940s, are lipopeptides produced by Paenibacillus polymyxa


    The team of Professor Li Jian of Monash University used chemical biological methods to systematically change multiple non-conserved positions in the molecular structure of polymyxin, realizing the separation of therapeutic efficacy and toxicity for the first time, and successfully developed a new generation of polypeptide antibiotics F365 ( QPX9003)


    ▲Chemical structure and lipopeptide design strategy of polymyxin


    Through systematic analysis of the structure-activity model of polymyxin, Professor Li Jian's team found that the N-terminal fatty acyl group, the 3-diaminobutyric acid (Dab) residue and the 6- and 7-amino acid residues are the most common in natural polymyxins.


    ▲ Nephrotoxicity, acute toxicity, and in vitro activity of polymyxins and lead compounds in mice


    Experiments show that for Pseudomonas aeruginosa and Acinetobacter baumannii, the activity of F365 is 2 times and 8 times higher than that of polymyxin B, respectively


    Transcriptomic analysis showed that Acinetobacter baumannii gene expression was significantly affected after polymyxin and F365 treatment


    ▲Transcriptome changes in Acinetobacter baumannii AB5075 and HK-2 cells after treatment with polymyxin B, colistin, F287, F319 and F365


    Matrix-enhanced surface-assisted laser desorption/ionization mass spectrometry imaging (ME-SALDI-MS) results revealed very different distribution, accumulation, and metabolism of F365 compared with polymyxin B and colistin in mouse kidney tissue


    ▲Matrix-enhanced surface-assisted laser desorption/ionization mass spectrometry imaging of the distribution, accumulation and metabolism of polymyxin and F365 in mouse kidney


    References:

    [1] Roberts, KD, Zhu, Y.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.